Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28874774 | 0.95 | ALDH1A1 (0.50) | ALDH1A1TSHRTDP1CYP3A4L3MBTL1 | |
| SCHEMBL25181786 | 0.92 | TSHR (0.50) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| SCHEMBL1902657 | 0.90 | TSHR (0.54) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| SCHEMBL399748 | 0.90 | TSHR (0.54) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| SCHEMBL25181816 | 0.90 | TSHR (0.54) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| SCHEMBL25181815 | 0.90 | TSHR (0.54) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| SCHEMBL25182587 | 0.90 | TSHR (0.54) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| Ammonia Solution, Strong SCHEMBL27512615 | 0.88 | TSHR (0.52) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| Ammonia Solution, Strong SCHEMBL27496389 | 0.88 | TSHR (0.52) | ALDH1A1TSHRTDP1CYP3A4LMNA | |
| Ammonia Solution, Strong SCHEMBL27498065 | 0.88 | TSHR (0.52) | ALDH1A1TSHRTDP1CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104109064-B | A kind of method of ethylene oligomerization | 中国石油化工股份有限公司 | 2018-03-02 | — | — | CN | claimed |
| CN-104447161-B | Ethylene oligomerization method | 中国石油化工股份有限公司 | 2016-09-21 | — | — | CN | claimed |
| CN-104628503-B | A kind of method of ethylene oligomerization | 中国石油化工股份有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-104628502-B | A kind of method of ethylene oligomerization | 中国石油化工股份有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-104418690-B | A kind of method of ethylene oligomerization | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-104557372-B | A kind of method of ethylene oligomerization | SINOPEC CORP. (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-104628502-A | Oligomerization method of ethylene | CHINA PETROLEUM & CHEMICAL | 2015-05-20 | — | — | CN | claimed |
| CN-104628503-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-05-20 | — | — | CN | claimed |
| CN-104557372-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| CN-104447161-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-03-25 | — | — | CN | claimed |
| CN-104418690-A | Method for oligomerization of ethylene | CHINA PETROLEUM & CHEMICAL | 2015-03-18 | — | — | CN | claimed |
| CN-104109064-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2014-10-22 | — | — | CN | claimed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| EP-3694829-B1 | SYNTHESIS OF ALIPHATIC ALCOHOLS AS AROMA CHEMICALS | BASF SE (DE) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-11286224-B2 | Synthesis of aliphatic alcohols as aroma chemicals | BASF SE (DE) | 2022-03-29 | — | — | US | disclosed |
| WO-2005068548-A1 | EXTRUSION COATING POLYETHYLENE | BOREALIS TECHNOLOGY OY (FI) | 2005-07-28 | — | — | WO | disclosed |
| EP-1555292-A1 | Extrusion coating polyethylene | Borealis Technology Oy (FI) | 2005-07-20 | — | — | EP | disclosed |
| EP-1460105-A1 | Polymer composition | Borealis Technology Oy (FI) | 2004-09-22 | — | — | EP | disclosed |
| US-4440940-A | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286224-B2 | Synthesis of aliphatic alcohols as aroma chemicals | ADH1A, ADH1C, ADH5 | ALDH1A1 4/4885TSHR 3523/4885TDP1 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.